Frontlight ResearchEarly access
Trial site
Re:Cognition Health - Bristol
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease8 trials
- Mild cognitive impairment2 trials
- Migraine1 trial
- Phase
- Phase 25 trials
- Phase 33 trials
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Alector Inc.2 trials
- Biogen2 trials
- Eli Lilly and Company2 trials
- Acumen Pharmaceuticals1 trial
- Janssen Pharmaceutica N.V., Belgium1 trial
- and 1 more
Running trials
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026